News Agency News Aggregator Journalist/Editor Broking House Others
Pfizer and BioNTech build the case that their Covid-19 vaccine will protect against the new variant of the coronavirus that emerged in the U.K.
[email protected] had granted emergency use validation for Pfizer-BioNTech Covid19vaccine on December 31, 2020, opening the door for countries to expedite their own regulatory approval processes to import and administer vaccine. #VaccineStrategy #VaccinationDrive
The @WHO has reached an agreement with @pfizer /@BioNTech_Group for 40 million doses of its #COVID19 vaccine, should be able to start delivering vaccines to poor, lower-middle income countries next month. #Vaccine #Pfizer #BioNTech #health
Coronavirus News LIVE | WHO says Pfizer deal may allow poor countries to start COVID-19 vaccination in February. Stay tuned to @moneycontrolcom for the latest updates on #Coronavirus. #Covid19 #Covid_19 | Track LIVE:
Italy is threatening legal action against Pfizer for the delays after it was told to expect a 20% cut next week after a reduction in this week's supply of almost 30%. Czech Health Minister Jan Blatny said Pfizer deliveries to his country were also falling.
Pfizer and BioNTech will supply as many as 40 million doses of their Covid-19 vaccine to Covax, a global alliance many poorer countries are relying on to protect their populations.
#NewsAlert: The WHO and Pfizer announced a deal for up to 40 million initial doses of the Pfizer-BioNTech #covidvaccine for poorer countries, through COVAX global pool. (AFP) Track today's latest news here:
The World Health Organization says there's no evidence that Pfizer and BioNTech’s Covid-19 vaccine contributed to the deaths of elderly people